WesBanco Bank’s AtriCure ATRC Stock Holding History

WesBanco Bank’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,525	Closed	-$354K	–	617
2024 Q2	$354K	Hold	15,525	–	–	0.01%	462
2024 Q1	$472K	Buy	+15,525	New	+$520K	0.02%	423
2023 Q4	–	Sell	-15,525	Closed	-$680K	–	395
2023 Q3	$680K	Buy	15,525 +9,000	+138%	+$439K	0.03%	345
2023 Q2	$322K	Hold	6,525	–	–	0.01%	477
2023 Q1	$270K	Hold	6,525	–	–	0.01%	506
2022 Q4	$290K	Buy	+6,525	New	+$273K	0.01%	499
2022 Q3	–	Sell	-6,525	Closed	-$267K	–	374
2022 Q2	$267K	Hold	6,525	–	–	0.01%	490
2022 Q1	$428K	Hold	6,525	–	–	0.02%	438
2021 Q4	$454K	Sell	6,525 -3,525	-35%	-$256K	0.02%	434
2021 Q3	$699K	Hold	10,050	–	–	0.03%	355
2021 Q2	$797K	Sell	10,050 -3,000	-23%	-$218K	0.03%	336
2021 Q1	$855K	Buy	+13,050	New	+$804K	0.03%	316
2020 Q3	$647K	Hold	16,227	–	–	0.03%	321
2020 Q2	$729K	Hold	16,227	–	–	0.04%	297
2020 Q1	$545K	Hold	16,227	–	–	0.03%	313
2019 Q4	$528K	Buy	+16,227	New	+$462K	0.02%	366

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

WesBanco Bank's ATRC Position: Q3 2024 in Review

WesBanco Bank sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 15,525 shares — an estimated $354K sold.

WesBanco Bank first reported a position in ATRC in Q4 2019 and held it in 16 quarters. The position peaked at $855K in Q1 2021. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

WesBanco Bank reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
WesBanco Bank sold 15,525 AtriCure shares in Q3 2024, an estimated $354K.
WesBanco Bank first reported a position in AtriCure in Q4 2019 and held it in 16 quarters.
WesBanco Bank's AtriCure position peaked at $855K in Q1 2021.
201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on WesBanco Bank's 13F filing for Q3 2024, filed 11 Oct 2024.